Last night I began my treatment plan! The nurse from Life IVF Center in Irvine, CA sent me a big email full of results and a plan for the the coming week.
The cliff notes version is that everything is on track and I am now taking an oral medication called Estrace (more information below). I will be taking it once daily through tomorrow then increasing to twice a day. At the end of the week I will also have additional blood work and a monitoring appointment at Texas Fertility Center. They have not given me a transfer date yet but if it is supposed to be around CD23 then it will approximately be April 3rd.
For a more in depth look at the results, medication, and type of blood tests with reference values please see the fun facts listed below.
Below are the results from your CD2 appt:
Endometrial Lining: 4.8mm
Right Side Follicles: 6mm, 5mm and 5 of <5mm
Left Side Follicles: 9mm, 8mm and 5 of <8mm
Doctor’s recommended plan is as follows:
1) Estrace 2mg, 1 tablet by mouth once daily, starting on your CD5 (3/16) and continue for 3 days. Then increase to 1 tablet by mouth-twice a day daily, starting on your CD8 (3/19) and continue.
2) Please follow up on your CD10 (3/21) to check your E2, FSH, LH, P4 and ultrasound.
What is Estrace?
Estrace is a medicine that contains estrogen hormones.
E2 Reference Values in Adult Females
Premenopausal: 15-350 pg/mL**
Postmenopausal: <10 pg/mL
**E2 levels vary widely through the menstrual cycle.
FSH in Adult Females
Gonadotropin-releasing hormone from the hypothalamus controls the secretion of the gonadotropins, follicle-stimulating hormone (FSH) and luteinizing hormone (LH) from the anterior pituitary. The menstrual cycle is divided by a midcycle surge of both FSH and LH into a follicular phase and a luteal phase. FSH appears to control gametogenesis in both males and females.
> or =18 years: Premenopausal
Follicular: 3.9-8.8 IU/L
Midcycle: 4.5-22.5 IU/L
Luteal: 1.8-5.1 IU/L
Postmenopausal: 16.7-113.6 IU/L
P4 (Progesterone, Serum) in Adult Females
Sources of progesterone are the adrenal glands, corpus luteum, and placenta. Useful for ascertaining whether ovulation occurred in a menstrual cycle.
Follicular phase: 0.20-1.50 ng/mL
Ovulation phase: 0.80-3.00 ng/mL
Luteal phase: 1.70-27.00 ng/mL
Postmenopausal: <0.15-0.80 ng/mL